• OPEN AN ACCOUNT
Indian Indices
Sensex
72,529.07 -242.65
( -0.33%)
Global Indices
Nasdaq
51,510.98 -338.64
(-0.65%)
Dow Jones
7,705.40 -59.01
(-0.76%)
Hang Seng
65,155.57 -722.05
(-1.10%)
Nikkei 225
10,700.56 5.31
(0.05%)
Forex
USD-INR
95.79 -0.10
(-0.10%)
EUR-INR
109.09 0.01
(0.01%)
GBP-INR
126.83 0.01
(0.01%)
JPY-INR
0.61 0.00
(0.68%)

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532531
INE939A01011
356.2353295
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
STAR
58.92
10612.31
EPS(TTM)
Face Value()
Div & Yield %
19.54
10
0.43
 

music broadcast ltd
Sampann Utpadan India consolidated net profit declines 77.98% in the March 2026 quarter
Apr 25,2026
Net profit of Sampann Utpadan India declined 77.98% to Rs 1.20 crore in the quarter ended March 2026 as against Rs 5.45 crore during the previous quarter ended March 2025. Sales rose 19.67% to Rs 38.75 crore in the quarter ended March 2026 as against Rs 32.38 crore during the previous quarter ended March 2025.

For the full year,net profit rose 70.35% to Rs 6.78 crore in the year ended March 2026 as against Rs 3.98 crore during the previous year ended March 2025. Sales rose 46.28% to Rs 142.64 crore in the year ended March 2026 as against Rs 97.51 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales38.7532.38 20 142.6497.51 46
OPM %8.8012.75 -10.833.76 -
PBDT3.214.00 -20 15.012.98 404
PBT1.602.59 -38 9.06-2.73 LP
NP1.205.45 -78 6.783.98 70